C. Schlotter

发表

Neoadjuvant chemotherapy for breast cancer with weekly nab-paclitaxel followed by epirubicin and cyclophosphamide--results of a case series.

H. Ulmer, A. Hahn, C. Schlotter, 2014, In vivo.

Relationship of c-myc and erbB oncogene family gene aberrations and other selected factors to ex vivo chemosensitivity of ovarian cancer in the modified ATP-chemosensitivity assay.

C. Schlotter, K. Bielawski, U. Bosse, 2000, Acta biochimica Polonica.

Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer.

A. Podhajska, C. Schlotter, K. Bielawski, 1998, Gene.

Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid.

C. Schlotter, K. Bielawski, U. Bosse, 2004, Oncology reports.

Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis.

G. Assmann, C. Jackisch, B. Brandt, 1995, Gene.

C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer

C. Schlotter, U. Bosse, U. Vogt, 2003, Breast Cancer Research.

Whole Genome Expression Analysis for Biologic Rational Pathway Modeling

B. Brandt, N. Tidow, A. Marra, 2012, Molecular Diagnosis & Therapy.

c-myc oncogene gene dosage, serum CEA and CA-15.3 antigen levels, and cellular DNA values in relation to ex vivo chemosensitivity of primary human breast cancer.

C. Schlotter, K. Bielawski, U. Bosse, 2000, Acta biochimica Polonica.

Ki67 and lymphocytes in the pretherapeutic core biopsy of primary invasive breast cancer: positive markers of therapy response prediction and superior survival

A. Hahn, C. Schlotter, L. Tietze, 2017, Hormone molecular biology and clinical investigation.

Molecular targeted therapies for breast cancer treatment

Heike Allgayer, H. Allgayer, B. Brandt, 2008, Breast Cancer Research.

Evaluation of infants with acidosis using a perinatal “Negative factor” score

R. Michaelis, C. Schlotter, R. Dopfer, 2005, Archives of gynecology.

Squalene epoxidase, located on chromosome 8q24.1, is upregulated in 8q+ breast cancer and indicates poor clinical outcome in stage I and II disease

H Buerger, E Korsching, H. Pospisil, 2008, British Journal of Cancer.

Review Molecular targeted therapies for breast cancer treatment

C. M. Schlotter, Heike Allgayer, H. Allgayer, 2008 .